COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN AZERBAIJAN

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Environmental Factors Support Sales Growth in 2018

Products With Mixed Ingredients Benefit From Softer Price Regulation in 2018

Drugstores/parapharmacies Gains the Upper Hand

Competitive Landscape

Drogsan Illaclari and Gsk Consumer Healthcare Continue To Lead in 2018

International Brands Hold Sway

Higher-quality and Added-value Products Stimulate Value

Category Data

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2013-2018

Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2013-2018

Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2018

Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2018

Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023

Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023

Executive Summary

Price Regulation Affects Value Sales Dynamics

Economic Stability and Consumer Awareness Support Growth in 2018

Lower-priced and Local Brands Gain Ground

Drugstores/parapharmacies Continues To Grow in 2018

Consumer Health Is Set To Develop Over the Forecast Period

Market Indicators

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 8 Life Expectancy at Birth 2013-2018

Market Data

Table 9 Sales of Consumer Health by Category: Value 2013-2018

Table 10 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 11 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 12 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 13 Distribution of Consumer Health by Format: % Value 2013-2018

Table 14 Distribution of Consumer Health by Format and Category: % Value 2018

Table 15 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Sources

Summary 1 Research Sources

Over the review period, cough, cold and allergy (hay fever) remedies remained highly dependent on seasonality. These products were mainly consumed between autumn and spring. Growing urbanisation and rising pollution increases the number of allergy-sensitive consumers and supported positive sales of allergy (hay fever) remedies. With rising consumer knowledge of ingredients, sales of herbal options grew in 2018.

Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Azerbaijan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.